| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 16 | 2020 | 325 | 5.020 |
Why?
|
| Proteins | 23 | 2020 | 695 | 4.970 |
Why?
|
| Algorithms | 25 | 2020 | 883 | 4.760 |
Why?
|
| Computational Biology | 24 | 2020 | 285 | 4.440 |
Why?
|
| Molecular Docking Simulation | 8 | 2020 | 55 | 3.830 |
Why?
|
| Genome, Human | 10 | 2021 | 202 | 2.940 |
Why?
|
| Transcription Factors | 14 | 2022 | 1398 | 2.680 |
Why?
|
| RNA, Small Interfering | 31 | 2021 | 778 | 2.680 |
Why?
|
| Gene Expression Regulation | 19 | 2022 | 1525 | 2.610 |
Why?
|
| Protein Interaction Mapping | 7 | 2020 | 67 | 2.550 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 6 | 2022 | 93 | 2.440 |
Why?
|
| Epigenesis, Genetic | 9 | 2021 | 307 | 2.300 |
Why?
|
| Genomics | 7 | 2022 | 254 | 2.300 |
Why?
|
| Transcription, Genetic | 12 | 2021 | 870 | 2.260 |
Why?
|
| Histones | 14 | 2021 | 433 | 2.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 12 | 2016 | 241 | 2.180 |
Why?
|
| Databases, Genetic | 7 | 2022 | 78 | 1.930 |
Why?
|
| Sequence Analysis, DNA | 11 | 2016 | 366 | 1.900 |
Why?
|
| Sequence Analysis, RNA | 6 | 2019 | 136 | 1.830 |
Why?
|
| Chromatin | 12 | 2021 | 526 | 1.810 |
Why?
|
| Prefrontal Cortex | 7 | 2019 | 87 | 1.720 |
Why?
|
| Binding Sites | 23 | 2022 | 849 | 1.710 |
Why?
|
| Models, Molecular | 18 | 2018 | 1069 | 1.700 |
Why?
|
| Protein Conformation | 19 | 2018 | 736 | 1.690 |
Why?
|
| Protein Binding | 21 | 2020 | 1532 | 1.690 |
Why?
|
| Peptides | 8 | 2020 | 501 | 1.680 |
Why?
|
| Promoter Regions, Genetic | 14 | 2021 | 644 | 1.530 |
Why?
|
| Drosophila Proteins | 24 | 2021 | 714 | 1.530 |
Why?
|
| Drosophila melanogaster | 21 | 2021 | 483 | 1.440 |
Why?
|
| Databases, Protein | 8 | 2018 | 41 | 1.360 |
Why?
|
| Nucleotide Motifs | 5 | 2022 | 42 | 1.340 |
Why?
|
| DNA Transposable Elements | 11 | 2021 | 114 | 1.330 |
Why?
|
| Argonaute Proteins | 18 | 2021 | 116 | 1.320 |
Why?
|
| Chromatin Assembly and Disassembly | 6 | 2021 | 210 | 1.300 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 302 | 1.210 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2017 | 256 | 1.200 |
Why?
|
| Transcriptome | 6 | 2022 | 278 | 1.160 |
Why?
|
| Genome | 9 | 2021 | 203 | 1.120 |
Why?
|
| DNA | 6 | 2012 | 688 | 1.110 |
Why?
|
| Chromatin Immunoprecipitation | 9 | 2014 | 152 | 1.090 |
Why?
|
| Animals | 72 | 2022 | 17806 | 1.060 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 92 | 0.980 |
Why?
|
| Huntington Disease | 4 | 2015 | 128 | 0.940 |
Why?
|
| Sequence Alignment | 6 | 2016 | 283 | 0.920 |
Why?
|
| RNA Splicing | 5 | 2019 | 167 | 0.910 |
Why?
|
| Humans | 63 | 2022 | 48178 | 0.870 |
Why?
|
| Thermodynamics | 10 | 2017 | 190 | 0.850 |
Why?
|
| RNA, Messenger | 16 | 2020 | 1428 | 0.820 |
Why?
|
| RNA, Small Untranslated | 2 | 2016 | 10 | 0.820 |
Why?
|
| Alu Elements | 1 | 2019 | 7 | 0.820 |
Why?
|
| Transcription Initiation Site | 7 | 2021 | 44 | 0.810 |
Why?
|
| Molecular Sequence Annotation | 3 | 2019 | 52 | 0.800 |
Why?
|
| Peptide Initiation Factors | 8 | 2019 | 33 | 0.800 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 40 | 0.800 |
Why?
|
| Germ Cells | 8 | 2021 | 91 | 0.770 |
Why?
|
| RNA Polymerase II | 2 | 2018 | 73 | 0.770 |
Why?
|
| DNA Methylation | 7 | 2021 | 261 | 0.760 |
Why?
|
| Databases, Factual | 3 | 2017 | 719 | 0.720 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 82 | 0.720 |
Why?
|
| MicroRNAs | 11 | 2020 | 628 | 0.710 |
Why?
|
| Gene Silencing | 10 | 2021 | 346 | 0.690 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 134 | 0.680 |
Why?
|
| CRISPR-Cas Systems | 6 | 2021 | 255 | 0.680 |
Why?
|
| Influenza A Virus, H7N9 Subtype | 2 | 2013 | 10 | 0.670 |
Why?
|
| Genes, Viral | 2 | 2013 | 62 | 0.660 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2015 | 35 | 0.650 |
Why?
|
| Antibodies, Neutralizing | 2 | 2017 | 188 | 0.640 |
Why?
|
| Organ Specificity | 5 | 2021 | 170 | 0.640 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2017 | 118 | 0.630 |
Why?
|
| Cluster Analysis | 5 | 2016 | 246 | 0.630 |
Why?
|
| Mutation | 13 | 2020 | 2192 | 0.630 |
Why?
|
| Chromosome Breakpoints | 1 | 2015 | 4 | 0.620 |
Why?
|
| Genomic Structural Variation | 1 | 2015 | 3 | 0.620 |
Why?
|
| Biological Evolution | 3 | 2020 | 101 | 0.610 |
Why?
|
| Internet | 8 | 2020 | 465 | 0.590 |
Why?
|
| Antigens, CD1d | 1 | 2014 | 30 | 0.580 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2014 | 121 | 0.580 |
Why?
|
| Gene Ontology | 3 | 2021 | 29 | 0.580 |
Why?
|
| Antigens, CD1 | 1 | 2014 | 41 | 0.570 |
Why?
|
| Exons | 4 | 2018 | 176 | 0.570 |
Why?
|
| Epigenomics | 3 | 2021 | 55 | 0.570 |
Why?
|
| Viral Envelope Proteins | 2 | 2017 | 107 | 0.570 |
Why?
|
| Neurons | 8 | 2019 | 781 | 0.560 |
Why?
|
| RNA Processing, Post-Transcriptional | 4 | 2018 | 83 | 0.560 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 69 | 0.550 |
Why?
|
| Vitamins | 1 | 2014 | 70 | 0.550 |
Why?
|
| ran GTP-Binding Protein | 1 | 2013 | 4 | 0.540 |
Why?
|
| Histocompatibility Antigens | 2 | 2013 | 101 | 0.540 |
Why?
|
| Protein Interaction Maps | 1 | 2013 | 27 | 0.540 |
Why?
|
| Benchmarking | 3 | 2020 | 122 | 0.540 |
Why?
|
| Hepatitis C, Chronic | 1 | 2014 | 68 | 0.530 |
Why?
|
| Multiprotein Complexes | 2 | 2014 | 142 | 0.530 |
Why?
|
| Human Development | 1 | 2013 | 9 | 0.530 |
Why?
|
| Sea Urchins | 1 | 2013 | 36 | 0.510 |
Why?
|
| Structural Homology, Protein | 3 | 2020 | 19 | 0.510 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 5 | 0.500 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 15 | 0.500 |
Why?
|
| Embryonic Stem Cells | 4 | 2014 | 140 | 0.490 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 789 | 0.490 |
Why?
|
| Liver Neoplasms | 3 | 2021 | 228 | 0.480 |
Why?
|
| Models, Genetic | 2 | 2014 | 248 | 0.480 |
Why?
|
| Mice | 26 | 2022 | 8956 | 0.480 |
Why?
|
| Caenorhabditis elegans | 5 | 2018 | 540 | 0.470 |
Why?
|
| Peptide Library | 1 | 2011 | 34 | 0.470 |
Why?
|
| Liver Transplantation | 1 | 2014 | 178 | 0.470 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2021 | 595 | 0.460 |
Why?
|
| RNA Helicases | 5 | 2019 | 91 | 0.460 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2018 | 350 | 0.450 |
Why?
|
| Chromosomal Proteins, Non-Histone | 6 | 2021 | 152 | 0.450 |
Why?
|
| Ligands | 6 | 2020 | 391 | 0.450 |
Why?
|
| Chromosome Mapping | 5 | 2014 | 283 | 0.450 |
Why?
|
| Models, Statistical | 2 | 2012 | 306 | 0.440 |
Why?
|
| RNA Polymerase III | 2 | 2021 | 8 | 0.440 |
Why?
|
| Cell Line | 9 | 2020 | 1950 | 0.430 |
Why?
|
| Models, Chemical | 2 | 2010 | 131 | 0.430 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 84 | 0.430 |
Why?
|
| Amino Acid Sequence | 9 | 2020 | 1577 | 0.420 |
Why?
|
| RNA, Guide | 4 | 2021 | 111 | 0.420 |
Why?
|
| Biomarkers | 1 | 2014 | 957 | 0.400 |
Why?
|
| Retroelements | 4 | 2015 | 35 | 0.400 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 815 | 0.400 |
Why?
|
| Ovary | 6 | 2019 | 103 | 0.400 |
Why?
|
| Nucleosomes | 5 | 2014 | 189 | 0.400 |
Why?
|
| Neoplasms | 2 | 2015 | 923 | 0.390 |
Why?
|
| Gene Editing | 4 | 2021 | 221 | 0.390 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2021 | 15 | 0.390 |
Why?
|
| Evolution, Molecular | 5 | 2019 | 267 | 0.380 |
Why?
|
| Viral Proteins | 4 | 2015 | 272 | 0.380 |
Why?
|
| Base Composition | 2 | 2021 | 29 | 0.360 |
Why?
|
| Base Sequence | 12 | 2020 | 1286 | 0.360 |
Why?
|
| Genome, Insect | 3 | 2013 | 28 | 0.360 |
Why?
|
| Adenine | 2 | 2020 | 36 | 0.350 |
Why?
|
| Hepatocytes | 2 | 2021 | 158 | 0.350 |
Why?
|
| Testis | 3 | 2019 | 131 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 375 | 0.350 |
Why?
|
| Chromosomes, Human | 3 | 2021 | 48 | 0.350 |
Why?
|
| Spermatogenesis | 2 | 2020 | 60 | 0.330 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 259 | 0.330 |
Why?
|
| RNA-Induced Silencing Complex | 6 | 2011 | 67 | 0.330 |
Why?
|
| Protein Multimerization | 2 | 2020 | 149 | 0.320 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2019 | 129 | 0.320 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2006 | 7 | 0.320 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2018 | 73 | 0.320 |
Why?
|
| Drosophila | 4 | 2021 | 447 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 289 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 2863 | 0.300 |
Why?
|
| Molecular Sequence Data | 11 | 2016 | 1983 | 0.300 |
Why?
|
| Amino Acid Motifs | 2 | 2021 | 154 | 0.300 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 1120 | 0.290 |
Why?
|
| Research Design | 2 | 2020 | 528 | 0.290 |
Why?
|
| Exoribonucleases | 2 | 2016 | 24 | 0.280 |
Why?
|
| Schizosaccharomyces | 2 | 2018 | 106 | 0.280 |
Why?
|
| Heterochromatin | 4 | 2018 | 69 | 0.270 |
Why?
|
| Gene Expression Profiling | 9 | 2020 | 674 | 0.270 |
Why?
|
| Protein Folding | 4 | 2003 | 244 | 0.270 |
Why?
|
| Antibodies, Viral | 2 | 2017 | 301 | 0.270 |
Why?
|
| Nucleotides | 2 | 2020 | 33 | 0.270 |
Why?
|
| Alleles | 5 | 2020 | 398 | 0.260 |
Why?
|
| Methylation | 5 | 2019 | 112 | 0.260 |
Why?
|
| Deoxyribonuclease I | 2 | 2012 | 39 | 0.250 |
Why?
|
| Genes, Insect | 2 | 2020 | 91 | 0.250 |
Why?
|
| Oligonucleotides | 1 | 2004 | 134 | 0.250 |
Why?
|
| Olfactory Bulb | 1 | 2022 | 13 | 0.240 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2022 | 15 | 0.240 |
Why?
|
| Female | 19 | 2020 | 26282 | 0.240 |
Why?
|
| Models, Biological | 9 | 2020 | 1131 | 0.240 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 237 | 0.230 |
Why?
|
| RNA Interference | 3 | 2011 | 597 | 0.230 |
Why?
|
| Genome Components | 1 | 2021 | 4 | 0.230 |
Why?
|
| TATA Box | 1 | 2021 | 18 | 0.230 |
Why?
|
| Antibodies | 3 | 2017 | 171 | 0.230 |
Why?
|
| Genes, Essential | 1 | 2021 | 14 | 0.230 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2021 | 4 | 0.230 |
Why?
|
| Hepatoblastoma | 1 | 2021 | 5 | 0.230 |
Why?
|
| Introns | 2 | 2018 | 107 | 0.220 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1242 | 0.220 |
Why?
|
| RNA Cleavage | 3 | 2015 | 8 | 0.220 |
Why?
|
| Influenza, Human | 2 | 2013 | 186 | 0.220 |
Why?
|
| Repressor Proteins | 2 | 2021 | 326 | 0.220 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2020 | 8 | 0.220 |
Why?
|
| Manduca | 1 | 2020 | 26 | 0.220 |
Why?
|
| Genetic Therapy | 2 | 2018 | 569 | 0.220 |
Why?
|
| Muscular Atrophy | 1 | 2020 | 23 | 0.220 |
Why?
|
| Gestational Age | 1 | 2021 | 157 | 0.220 |
Why?
|
| Genetic Vectors | 4 | 2018 | 683 | 0.210 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2020 | 10 | 0.210 |
Why?
|
| Data Curation | 1 | 2020 | 3 | 0.210 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2020 | 20 | 0.210 |
Why?
|
| Habenula | 1 | 2020 | 13 | 0.210 |
Why?
|
| Phascolarctidae | 1 | 2019 | 3 | 0.210 |
Why?
|
| Gammaretrovirus | 1 | 2019 | 6 | 0.210 |
Why?
|
| Interpeduncular Nucleus | 1 | 2020 | 17 | 0.210 |
Why?
|
| Cross-Linking Reagents | 2 | 2018 | 118 | 0.200 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2014 | 359 | 0.200 |
Why?
|
| Uridine | 2 | 2020 | 17 | 0.200 |
Why?
|
| Male | 18 | 2020 | 23370 | 0.200 |
Why?
|
| RNA | 2 | 2014 | 357 | 0.200 |
Why?
|
| Phenotype | 6 | 2022 | 990 | 0.200 |
Why?
|
| Endoribonucleases | 2 | 2019 | 50 | 0.200 |
Why?
|
| Machine Learning | 1 | 2020 | 85 | 0.190 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2020 | 96 | 0.190 |
Why?
|
| Mathematical Computing | 1 | 1998 | 13 | 0.190 |
Why?
|
| Binding Sites, Antibody | 1 | 1998 | 28 | 0.190 |
Why?
|
| Receptors, Fc | 1 | 1998 | 22 | 0.190 |
Why?
|
| A549 Cells | 1 | 2018 | 32 | 0.190 |
Why?
|
| Nicotine | 1 | 2020 | 124 | 0.190 |
Why?
|
| Antigen Presentation | 2 | 2014 | 224 | 0.190 |
Why?
|
| User-Computer Interface | 1 | 1999 | 126 | 0.190 |
Why?
|
| Sex Chromosomes | 1 | 2018 | 7 | 0.180 |
Why?
|
| Sex Determination Analysis | 1 | 2018 | 6 | 0.180 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1998 | 45 | 0.180 |
Why?
|
| Dependovirus | 3 | 2018 | 550 | 0.180 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2018 | 22 | 0.180 |
Why?
|
| Phylogeny | 3 | 2014 | 307 | 0.180 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2017 | 3 | 0.180 |
Why?
|
| Open Reading Frames | 1 | 2018 | 79 | 0.180 |
Why?
|
| Base Pairing | 3 | 2018 | 36 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 385 | 0.180 |
Why?
|
| Human Genome Project | 1 | 1997 | 6 | 0.180 |
Why?
|
| Calorimetry | 1 | 1997 | 36 | 0.180 |
Why?
|
| Cognition | 2 | 2019 | 342 | 0.180 |
Why?
|
| Spliceosomes | 1 | 2018 | 53 | 0.180 |
Why?
|
| Epitopes | 2 | 2017 | 290 | 0.180 |
Why?
|
| Mammals | 2 | 2022 | 113 | 0.180 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2018 | 45 | 0.180 |
Why?
|
| Ribonuclease III | 3 | 2012 | 75 | 0.170 |
Why?
|
| Biotechnology | 1 | 1997 | 44 | 0.170 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2018 | 80 | 0.170 |
Why?
|
| Schizophrenia | 1 | 2019 | 254 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 43 | 0.170 |
Why?
|
| Metadata | 1 | 2016 | 7 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 444 | 0.170 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2016 | 25 | 0.170 |
Why?
|
| Crystallography, X-Ray | 3 | 2014 | 379 | 0.170 |
Why?
|
| fas Receptor | 1 | 2017 | 55 | 0.170 |
Why?
|
| DNA Footprinting | 2 | 2014 | 17 | 0.160 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 1177 | 0.160 |
Why?
|
| Eukaryotic Initiation Factors | 3 | 2010 | 28 | 0.160 |
Why?
|
| RNA-Binding Proteins | 3 | 2019 | 384 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 69 | 0.160 |
Why?
|
| Brain | 2 | 2015 | 1129 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 93 | 0.160 |
Why?
|
| Genetic Variation | 3 | 2012 | 334 | 0.160 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2015 | 10 | 0.160 |
Why?
|
| Mitochondria | 1 | 2019 | 279 | 0.160 |
Why?
|
| RNA, Nuclear | 1 | 2015 | 11 | 0.160 |
Why?
|
| Hepacivirus | 1 | 2017 | 126 | 0.160 |
Why?
|
| Ribonucleoproteins | 2 | 2018 | 123 | 0.160 |
Why?
|
| Meiosis | 2 | 2013 | 59 | 0.160 |
Why?
|
| Bacterial Proteins | 4 | 2015 | 712 | 0.150 |
Why?
|
| Polynucleotide Adenylyltransferase | 1 | 2015 | 14 | 0.150 |
Why?
|
| DNA End-Joining Repair | 1 | 2015 | 21 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 188 | 0.150 |
Why?
|
| Recombinational DNA Repair | 1 | 2015 | 23 | 0.150 |
Why?
|
| Adult | 7 | 2019 | 13298 | 0.150 |
Why?
|
| Cell Nucleus | 4 | 2021 | 561 | 0.150 |
Why?
|
| Dipeptides | 1 | 2015 | 54 | 0.150 |
Why?
|
| Infant | 3 | 2019 | 1361 | 0.150 |
Why?
|
| Middle Aged | 7 | 2019 | 13615 | 0.150 |
Why?
|
| Caenorhabditis | 1 | 2014 | 14 | 0.150 |
Why?
|
| Oncogenes | 1 | 2015 | 60 | 0.150 |
Why?
|
| Transgenes | 2 | 2018 | 153 | 0.150 |
Why?
|
| Cytosine | 2 | 2011 | 23 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 78 | 0.150 |
Why?
|
| Huntingtin Protein | 1 | 2015 | 124 | 0.150 |
Why?
|
| Neostriatum | 1 | 2014 | 18 | 0.150 |
Why?
|
| Galactosylceramides | 1 | 2014 | 12 | 0.150 |
Why?
|
| Helminth Proteins | 1 | 2014 | 43 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 1788 | 0.140 |
Why?
|
| Vaccinia virus | 1 | 2015 | 103 | 0.140 |
Why?
|
| Corpus Striatum | 1 | 2015 | 73 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 49 | 0.140 |
Why?
|
| Pregnancy | 3 | 2019 | 1947 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 102 | 0.140 |
Why?
|
| Apoptosis | 1 | 2020 | 1004 | 0.140 |
Why?
|
| Child, Preschool | 3 | 2019 | 1775 | 0.140 |
Why?
|
| Aged | 5 | 2019 | 10902 | 0.140 |
Why?
|
| Genes, Homeobox | 1 | 2014 | 24 | 0.140 |
Why?
|
| Infant, Newborn | 2 | 2019 | 1042 | 0.140 |
Why?
|
| Glycosylation | 1 | 2014 | 134 | 0.140 |
Why?
|
| Prognosis | 2 | 2016 | 1260 | 0.140 |
Why?
|
| Frontotemporal Dementia | 1 | 2015 | 103 | 0.140 |
Why?
|
| Proteolysis | 1 | 2014 | 113 | 0.130 |
Why?
|
| Lysine | 2 | 2012 | 73 | 0.130 |
Why?
|
| Influenza in Birds | 1 | 2013 | 3 | 0.130 |
Why?
|
| Columbidae | 1 | 2013 | 12 | 0.130 |
Why?
|
| Support Vector Machine | 1 | 2013 | 21 | 0.130 |
Why?
|
| Reassortant Viruses | 1 | 2013 | 9 | 0.130 |
Why?
|
| Molecular Conformation | 1 | 2013 | 111 | 0.130 |
Why?
|
| Histone Acetyltransferases | 1 | 2013 | 64 | 0.130 |
Why?
|
| Mutation Rate | 1 | 2013 | 19 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 62 | 0.130 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 38 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2013 | 105 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2013 | 10 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 162 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 34 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 356 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 1998 | 924 | 0.130 |
Why?
|
| Fertility | 3 | 2020 | 81 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2014 | 562 | 0.130 |
Why?
|
| Recurrence | 1 | 2014 | 510 | 0.130 |
Why?
|
| Child | 4 | 2019 | 3775 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2014 | 268 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 54 | 0.120 |
Why?
|
| Poly A | 1 | 2012 | 29 | 0.120 |
Why?
|
| Entropy | 1 | 2012 | 19 | 0.120 |
Why?
|
| Adolescent | 4 | 2019 | 5498 | 0.120 |
Why?
|
| Genome, Fungal | 1 | 2012 | 40 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2012 | 47 | 0.120 |
Why?
|
| Replication Origin | 1 | 2012 | 33 | 0.120 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2011 | 18 | 0.120 |
Why?
|
| Proteome | 1 | 2012 | 96 | 0.120 |
Why?
|
| Spermatozoa | 1 | 2014 | 251 | 0.120 |
Why?
|
| Actins | 1 | 2013 | 244 | 0.110 |
Why?
|
| Genetic Loci | 3 | 2019 | 90 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2016 | 318 | 0.110 |
Why?
|
| Diet, Protein-Restricted | 1 | 2010 | 11 | 0.110 |
Why?
|
| Telomere | 1 | 2010 | 42 | 0.110 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 38 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2013 | 309 | 0.110 |
Why?
|
| DNA, Circular | 1 | 2010 | 4 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 404 | 0.110 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 74 | 0.110 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 242 | 0.110 |
Why?
|
| Gene Expression | 3 | 2011 | 773 | 0.110 |
Why?
|
| Oocytes | 1 | 2011 | 174 | 0.110 |
Why?
|
| Antibody Specificity | 1 | 2010 | 104 | 0.110 |
Why?
|
| Young Adult | 3 | 2019 | 3671 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 187 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 417 | 0.100 |
Why?
|
| RNA Stability | 1 | 2010 | 88 | 0.100 |
Why?
|
| Antigens, Viral | 3 | 1999 | 149 | 0.100 |
Why?
|
| RNA Transport | 1 | 2009 | 31 | 0.100 |
Why?
|
| Dimerization | 2 | 2013 | 142 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2010 | 139 | 0.100 |
Why?
|
| Ovarian Follicle | 1 | 2009 | 40 | 0.100 |
Why?
|
| Codon, Nonsense | 2 | 2020 | 46 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 197 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1960 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2010 | 123 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 589 | 0.100 |
Why?
|
| Signal Transduction | 5 | 2018 | 2711 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 4240 | 0.090 |
Why?
|
| Endonucleases | 2 | 2021 | 77 | 0.090 |
Why?
|
| Endopeptidases | 2 | 2000 | 62 | 0.090 |
Why?
|
| Pachytene Stage | 2 | 2020 | 8 | 0.090 |
Why?
|
| HLA-A2 Antigen | 2 | 2014 | 69 | 0.080 |
Why?
|
| RNA, Antisense | 2 | 2019 | 47 | 0.080 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2006 | 1 | 0.080 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2006 | 4 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 1 | 2006 | 13 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 665 | 0.080 |
Why?
|
| Time Factors | 2 | 2011 | 3230 | 0.080 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2005 | 3 | 0.080 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2005 | 7 | 0.080 |
Why?
|
| Genes, MHC Class I | 1 | 2005 | 30 | 0.080 |
Why?
|
| Macromolecular Substances | 2 | 2003 | 165 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 187 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2014 | 208 | 0.080 |
Why?
|
| Crystallization | 2 | 2003 | 88 | 0.080 |
Why?
|
| Random Allocation | 1 | 2006 | 200 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2016 | 63 | 0.070 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 6 | 0.070 |
Why?
|
| Macaca mulatta | 1 | 2005 | 204 | 0.070 |
Why?
|
| Access to Information | 1 | 2004 | 27 | 0.070 |
Why?
|
| Response Elements | 1 | 2004 | 35 | 0.070 |
Why?
|
| Autopsy | 2 | 2014 | 32 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2003 | 282 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2004 | 172 | 0.070 |
Why?
|
| Interleukin-18 | 1 | 2004 | 75 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2004 | 89 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2020 | 513 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2004 | 72 | 0.070 |
Why?
|
| Publishing | 1 | 2004 | 77 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2004 | 106 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2016 | 1918 | 0.060 |
Why?
|
| Systems Integration | 1 | 2003 | 28 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2019 | 287 | 0.060 |
Why?
|
| Fibronectins | 1 | 2002 | 32 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 442 | 0.060 |
Why?
|
| Rats | 2 | 2014 | 1796 | 0.060 |
Why?
|
| Breeding | 1 | 2022 | 25 | 0.060 |
Why?
|
| Odorants | 1 | 2022 | 15 | 0.060 |
Why?
|
| Smell | 1 | 2022 | 24 | 0.060 |
Why?
|
| Monocytes | 1 | 2004 | 339 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2003 | 123 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 2001 | 30 | 0.060 |
Why?
|
| Markov Chains | 1 | 2001 | 29 | 0.060 |
Why?
|
| Species Specificity | 2 | 2012 | 322 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2004 | 727 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 37 | 0.060 |
Why?
|
| Half-Life | 1 | 2021 | 63 | 0.060 |
Why?
|
| K562 Cells | 1 | 2021 | 57 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2017 | 360 | 0.060 |
Why?
|
| Dogs | 1 | 2022 | 293 | 0.060 |
Why?
|
| Contractile Proteins | 1 | 2020 | 13 | 0.060 |
Why?
|
| Muscles | 1 | 2001 | 164 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2014 | 2036 | 0.050 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2000 | 14 | 0.050 |
Why?
|
| Globins | 1 | 2000 | 27 | 0.050 |
Why?
|
| Codon | 1 | 2020 | 42 | 0.050 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2020 | 52 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2020 | 59 | 0.050 |
Why?
|
| HLA-DRB5 Chains | 1 | 2019 | 2 | 0.050 |
Why?
|
| Butyrophilins | 1 | 2019 | 3 | 0.050 |
Why?
|
| Transaldolase | 1 | 1999 | 1 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2000 | 76 | 0.050 |
Why?
|
| Gene Products, pol | 1 | 2019 | 9 | 0.050 |
Why?
|
| DNA Damage | 2 | 2012 | 281 | 0.050 |
Why?
|
| Cholesterol | 2 | 2012 | 271 | 0.050 |
Why?
|
| Profilins | 1 | 2020 | 33 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2019 | 20 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2021 | 108 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 1999 | 15 | 0.050 |
Why?
|
| HLA-B35 Antigen | 1 | 1999 | 5 | 0.050 |
Why?
|
| Gene Products, gag | 1 | 2019 | 62 | 0.050 |
Why?
|
| Sperm Capacitation | 1 | 2020 | 90 | 0.050 |
Why?
|
| Ribonucleases | 1 | 1999 | 29 | 0.050 |
Why?
|
| Plasmids | 1 | 2020 | 273 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 1999 | 19 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2020 | 174 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 1999 | 63 | 0.050 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2019 | 23 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2020 | 106 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2014 | 406 | 0.050 |
Why?
|
| Cochlea | 1 | 1999 | 18 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2020 | 126 | 0.050 |
Why?
|
| Autoantibodies | 1 | 1999 | 133 | 0.050 |
Why?
|
| Major Histocompatibility Complex | 1 | 1999 | 86 | 0.050 |
Why?
|
| Crystallography | 1 | 1998 | 26 | 0.050 |
Why?
|
| Kinetics | 1 | 2021 | 732 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2019 | 89 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 945 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2020 | 304 | 0.050 |
Why?
|
| Deafness | 1 | 1999 | 30 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2005 | 281 | 0.050 |
Why?
|
| HLA Antigens | 1 | 1998 | 47 | 0.050 |
Why?
|
| Chimera | 1 | 2018 | 39 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1999 | 170 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 365 | 0.050 |
Why?
|
| Transfection | 1 | 2020 | 644 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 1998 | 243 | 0.050 |
Why?
|
| RNA, Fungal | 1 | 2018 | 40 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 114 | 0.050 |
Why?
|
| Reproductive Isolation | 1 | 2017 | 3 | 0.050 |
Why?
|
| Sarcoma Virus, Woolly Monkey | 1 | 1997 | 1 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1997 | 19 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 1997 | 47 | 0.040 |
Why?
|
| Mitosis | 1 | 2019 | 205 | 0.040 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2018 | 77 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 1999 | 333 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 1999 | 169 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 1997 | 90 | 0.040 |
Why?
|
| Anxiety | 1 | 2020 | 272 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 1999 | 162 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 479 | 0.040 |
Why?
|
| HMGA2 Protein | 1 | 2016 | 3 | 0.040 |
Why?
|
| HMGA Proteins | 1 | 2016 | 4 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2016 | 6 | 0.040 |
Why?
|
| Butadienes | 1 | 2016 | 8 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2016 | 13 | 0.040 |
Why?
|
| beta Catenin | 1 | 2017 | 80 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 118 | 0.040 |
Why?
|
| Niacinamide | 1 | 2016 | 30 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 151 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 26 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 50 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 83 | 0.040 |
Why?
|
| Pyridones | 1 | 2016 | 23 | 0.040 |
Why?
|
| Liver | 2 | 2012 | 714 | 0.040 |
Why?
|
| Nitriles | 1 | 2016 | 52 | 0.040 |
Why?
|
| Drug Design | 1 | 2017 | 137 | 0.040 |
Why?
|
| ras Proteins | 1 | 2016 | 73 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2016 | 226 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2016 | 49 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 179 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2017 | 129 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 128 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 579 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2016 | 487 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2016 | 561 | 0.040 |
Why?
|
| Ovum | 1 | 2015 | 75 | 0.040 |
Why?
|
| Transcription Factor HES-1 | 1 | 2014 | 5 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 184 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 100 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 192 | 0.040 |
Why?
|
| Bombyx | 1 | 2014 | 8 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2015 | 109 | 0.040 |
Why?
|
| Cell Survival | 1 | 2017 | 519 | 0.040 |
Why?
|
| Chromosome Segregation | 1 | 2014 | 36 | 0.040 |
Why?
|
| Age of Onset | 1 | 2015 | 166 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2019 | 883 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2014 | 118 | 0.040 |
Why?
|
| SOXD Transcription Factors | 1 | 2014 | 5 | 0.040 |
Why?
|
| C9orf72 Protein | 1 | 2015 | 78 | 0.040 |
Why?
|
| Amino Acids | 1 | 1995 | 127 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1130 | 0.040 |
Why?
|
| CCCTC-Binding Factor | 1 | 2014 | 31 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 300 | 0.040 |
Why?
|
| MART-1 Antigen | 1 | 2014 | 5 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 810 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2014 | 24 | 0.040 |
Why?
|
| Histone Deacetylase 6 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 86 | 0.030 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2013 | 11 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 414 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 41 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 53 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 206 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2014 | 68 | 0.030 |
Why?
|
| Mushroom Bodies | 1 | 2013 | 3 | 0.030 |
Why?
|
| Point Mutation | 1 | 2014 | 159 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 33 | 0.030 |
Why?
|
| CpG Islands | 1 | 2014 | 206 | 0.030 |
Why?
|
| Contactins | 1 | 2012 | 4 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 643 | 0.030 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2012 | 10 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2013 | 37 | 0.030 |
Why?
|
| Macaca | 1 | 2012 | 23 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2012 | 19 | 0.030 |
Why?
|
| Chickens | 1 | 2013 | 101 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2012 | 33 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2013 | 72 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 57 | 0.030 |
Why?
|
| Nuclear Envelope | 1 | 2012 | 48 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 20 | 0.030 |
Why?
|
| United States | 1 | 2004 | 6137 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2012 | 14 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2011 | 19 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2012 | 60 | 0.030 |
Why?
|
| Chromosomes, Fungal | 1 | 2012 | 38 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 688 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 203 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2012 | 95 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 884 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2010 | 17 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 590 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 114 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 114 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 2010 | 17 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2010 | 13 | 0.030 |
Why?
|
| RNA Caps | 1 | 2010 | 16 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 147 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2010 | 45 | 0.030 |
Why?
|
| Cell Count | 1 | 2010 | 134 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2010 | 244 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2011 | 182 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 293 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 666 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2009 | 170 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 336 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 227 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 270 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2008 | 100 | 0.020 |
Why?
|
| Population | 1 | 2005 | 12 | 0.020 |
Why?
|
| SAIDS Vaccines | 1 | 2005 | 13 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2012 | 658 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2005 | 114 | 0.020 |
Why?
|
| Triazoles | 1 | 2005 | 58 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2005 | 100 | 0.020 |
Why?
|
| ROC Curve | 1 | 2005 | 235 | 0.020 |
Why?
|
| Multigene Family | 1 | 2004 | 96 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 443 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2005 | 560 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2002 | 16 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 855 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2002 | 104 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2004 | 407 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2002 | 213 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2002 | 128 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2002 | 120 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 328 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 429 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 326 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 745 | 0.010 |
Why?
|
| Cell Movement | 1 | 2002 | 389 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 898 | 0.010 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 1999 | 11 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1999 | 30 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 1999 | 33 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 8 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 1999 | 21 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 159 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 47 | 0.010 |
Why?
|
| Biophysics | 1 | 1999 | 40 | 0.010 |
Why?
|
| Diffusion | 1 | 1999 | 74 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 166 | 0.010 |
Why?
|
| Autoantigens | 1 | 1999 | 115 | 0.010 |
Why?
|
| Static Electricity | 1 | 1999 | 160 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 253 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 322 | 0.010 |
Why?
|
| Hydrocarbons | 1 | 1995 | 7 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1995 | 67 | 0.010 |
Why?
|
| Solubility | 1 | 1995 | 170 | 0.010 |
Why?
|
| Streptavidin | 1 | 1994 | 29 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1994 | 52 | 0.010 |
Why?
|
| Biotin | 1 | 1994 | 55 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1994 | 75 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1994 | 92 | 0.010 |
Why?
|